Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.24.2.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 143,904 $ 153,290
Short-term restricted cash   160
Short-term equity securities 696 161
Trade and other receivables, net 526 1,004
Short-term royalty and commercial payment receivables 14,257 14,215
Prepaid expenses and other current assets 2,820 483
Total current assets 162,203 169,313
Long-term restricted cash 6,016 6,100
Property and equipment, net 37 25
Operating lease right-of-use assets 349 378
Long-term royalty and commercial payment receivables 69,731 57,952
Exarafenib milestone asset (Note 4) 2,922  
Other assets - long term 2,022 533
Total assets 243,280 234,301
Current liabilities:    
Accounts payable 982 653
Accrued and other liabilities 4,869 2,768
Contingent consideration under RPAs, AAAs and CPPAs 3,000 7,000
Operating lease liabilities 421 54
Unearned revenue recognized under units-of-revenue method 2,259 2,113
Preferred stock dividend accrual 1,368 1,368
Current portion of long-term debt 5,716 5,543
Total current liabilities 18,615 19,499
Unearned revenue recognized under units-of-revenue method - long-term 5,963 7,228
Exarafenib milestone contingent consideration (Note 4) 2,922  
Long-term operating lease liabilities 710 335
Long-term debt 115,077 118,518
Total liabilities 143,287 145,580
Commitments and Contingencies (Note 10)
Stockholders' equity:    
Common stock, $0.0075 par value, 277,333,332 shares authorized, 11,658,383 and 11,495,492 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively 87 86
Additional paid-in capital 1,315,703 1,311,809
Accumulated deficit (1,215,846) (1,223,223)
Total stockholders' equity 99,993 88,721
Total liabilities and stockholders' equity 243,280 234,301
8.625% Series A Cumulative, Perpetual Preferred Stock    
Stockholders' equity:    
Preferred Stock 49 49
8.375% Series B Cumulative, Perpetual Preferred Stock    
Stockholders' equity:    
Preferred Stock
Convertible preferred stock    
Stockholders' equity:    
Preferred Stock